Anthony M. Manning, Chief Scientific Officer at MOMENTA PHARMACEUTICALS INC (MNTA), sold 347 shares at $32.36 ($11K) on 2020-08-10, disclosed to the SEC on 2020-08-11.
Scheduled sale ($11k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MNTA | SELL | 2020-08-13 | $12K | — | Filing → |
| MNTA | SELL | 2020-07-23 | $128K | — | Filing → |
| MNTA | SELL | 2020-07-21 | $3.5M | — | Filing → |